Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) EPS (Weighted Average and Diluted) (2022 - 2025)

Dna X (SONM) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$18.23 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 3405.77% year-over-year to -$18.23, compared with a TTM value of $20.23 through Sep 2025, up 800.0%, and an annual FY2024 reading of -$7.13, down 35550.0% over the prior year.
  • EPS (Weighted Average and Diluted) was -$18.23 for Q3 2025 at Dna X, down from -$0.99 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $39.37 in Q4 2024 and bottomed at -$18.23 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 4 years is $1.14, with a median of -$0.22 recorded in 2022.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 12800.0% in 2024, while the deepest fall reached 6600.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.15 in 2022, then crashed by 306.67% to -$0.31 in 2023, then surged by 12800.0% to $39.37 in 2024, then crashed by 146.3% to -$18.23 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SONM at -$18.23 in Q3 2025, -$0.99 in Q2 2025, and $0.08 in Q1 2025.